LOUIS SULLIVAN Insider Trading $EBS Emergent BioSolutions Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LOUIS SULLIVAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LOUIS SULLIVAN. LOUIS SULLIVAN is Director in HENRY SCHEIN INC ($HSIC) and Director in UNITED THERAPEUTICS Corp ($UTHR) and Director in ANI PHARMACEUTICALS INC ($ANIP) and Director in Emergent BioSolutions Inc. ($EBS).
LOUIS SULLIVAN in Emergent BioSolutions Inc.
Trading Symbol: EBSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LOUIS SULLIVAN: Director
Holdings: 43,063 shares
Current Value: $1,263,899
Latest Transaction: May 11 2021
$EBS Market Capitalization: $1.21B
$EBS Previous Close: $29.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of LOUIS SULLIVAN in Emergent BioSolutions Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANIP, EBS, HSIC, UTHR
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 18.64 | 10,305 | 192,085 | 0 | |
May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 61.62 | 3,118 | 192,131 | 39,945 | 43.1 K to 39.9 K (-7.24 %) |
May 11 2021 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 18.64 | 10,305 | 192,085 | 43,063 | 32.8 K to 43.1 K (+31.46 %) |
Sep 18 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Gift | G | 0.00 | 10,004 | 0 | 32,758 | 42.8 K to 32.8 K (-23.39 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 20.08 | 7,893 | 158,491 | 15,786 | |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 20.08 | 7,893 | 158,491 | 15,786 | |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.23 | 7,893 | 877,904 | 42,762 | 50.7 K to 42.8 K (-15.58 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.23 | 7,893 | 877,904 | 42,762 | 50.7 K to 42.8 K (-15.58 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 20.08 | 7,893 | 158,491 | 50,655 | 42.8 K to 50.7 K (+18.46 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 20.08 | 7,893 | 158,491 | 50,655 | 42.8 K to 50.7 K (+18.46 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.22 | 20,525 | 2,282,702 | 42,762 | 63.3 K to 42.8 K (-32.43 %) |
Sep 04 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 111.22 | 20,525 | 2,282,702 | 42,762 | 63.3 K to 42.8 K (-32.43 %) |
May 26 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 2,821 | 0 | 63,287 | 60.5 K to 63.3 K (+4.67 %) |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 13.00 | 7,893 | 102,609 | 0 | |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 14.71 | 7,893 | 116,106 | 0 | |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 58.96 | 7,893 | 465,357 | 60,466 | 68.4 K to 60.5 K (-11.55 %) |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 14.71 | 7,893 | 116,106 | 68,359 | 60.5 K to 68.4 K (+13.05 %) |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 58.96 | 7,893 | 465,357 | 60,466 | 68.4 K to 60.5 K (-11.55 %) |
Mar 06 2020 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 13.00 | 7,893 | 102,609 | 68,359 | 60.5 K to 68.4 K (+13.05 %) |
May 28 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 5,736 | 0 | 60,466 | 54.7 K to 60.5 K (+10.48 %) |
May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 13.37 | 7,893 | 105,529 | 0 | |
May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Payment of Exercise | F | 49.41 | 2,135 | 105,490 | 54,730 | 56.9 K to 54.7 K (-3.75 %) |
May 09 2019 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 13.37 | 7,893 | 105,529 | 56,865 | 49 K to 56.9 K (+16.12 %) |
May 24 2018 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 4,895 | 0 | 48,972 | 44.1 K to 49 K (+11.11 %) |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 18.64 | 905 | 16,869 | 10,305 | |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 13.00 | 693 | 9,009 | 7,893 | |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 13.37 | 693 | 9,265 | 7,893 | |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 20.08 | 693 | 13,915 | 7,893 | |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | J | 14.71 | 693 | 10,194 | 7,893 | |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 8,259 | 0 | 40,077 | 31.8 K to 40.1 K (+25.96 %) |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 577 | 0 | 35,818 | 35.2 K to 35.8 K (+1.64 %) |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 604 | 0 | 35,241 | 34.6 K to 35.2 K (+1.74 %) |
May 26 2017 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | J | 0.00 | 152 | 0 | 34,637 | 34.5 K to 34.6 K (+0.44 %) |
May 23 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 5,985 | 0 | 34,485 | 28.5 K to 34.5 K (+21.00 %) |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 11.67 | 21,600 | 252,072 | 0 | |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 8.76 | 21,600 | 189,216 | 0 | |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 8.43 | 4,131 | 34,824 | 0 | |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 8.43 | 300 | 2,529 | 4,131 | |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 39.28 | 21,600 | 848,448 | 28,500 | 50.1 K to 28.5 K (-43.11 %) |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 11.67 | 21,600 | 252,072 | 50,100 | 28.5 K to 50.1 K (+75.79 %) |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | S | 39.19 | 21,600 | 846,504 | 28,500 | 6.9 K to 28.5 K (+313.04 %) |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 8.76 | 21,600 | 189,216 | 50,100 | 28.5 K to 50.1 K (+75.79 %) |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 39.00 | 4,131 | 161,109 | 28,500 | 32.6 K to 28.5 K (-12.66 %) |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 8.43 | 4,131 | 34,824 | 32,631 | 28.5 K to 32.6 K (+14.49 %) |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 39.00 | 300 | 11,700 | 28,500 | 28.8 K to 28.5 K (-1.04 %) |
May 16 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 8.43 | 300 | 2,529 | 28,800 | 28.5 K to 28.8 K (+1.05 %) |
May 13 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 8.43 | 9,969 | 84,039 | 4,431 | |
May 13 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 39.25 | 9,969 | 391,283 | 28,500 | 38.5 K to 28.5 K (-25.91 %) |
May 13 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 8.43 | 9,969 | 84,039 | 38,469 | 28.5 K to 38.5 K (+34.98 %) |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 14,879 | 152,956 | 0 | |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 34.03 | 14,879 | 506,332 | 28,500 | 43.4 K to 28.5 K (-34.30 %) |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 14,879 | 152,956 | 43,379 | 28.5 K to 43.4 K (+52.21 %) |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 14,820 | 152,350 | 14,879 | |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 35.34 | 14,820 | 523,739 | 28,500 | 43.3 K to 28.5 K (-34.21 %) |
Mar 14 2016 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 14,820 | 152,350 | 43,320 | 28.5 K to 43.3 K (+52.00 %) |
Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Option Exercise | M | 10.28 | 13,457 | 138,338 | 29,699 | |
Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Sell | S | 31.33 | 13,457 | 421,541 | 28,500 | 42 K to 28.5 K (-32.07 %) |
Jun 17 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Buy | M | 10.28 | 13,457 | 138,338 | 41,957 | 28.5 K to 42 K (+47.22 %) |
May 21 2015 | EBS | Emergent BioSoluti ... | SULLIVAN LOUIS W | Director | Grant | A | 0.00 | 9,400 | 0 | 28,500 | 19.1 K to 28.5 K (+49.21 %) |
Page: 1